Norway Savings Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1M | Sell |
3,975
-402
| -9% | -$86.5K | 0.42% | 57 |
|
|
2026
Q1 | $952K | Sell |
4,377
-195
| -4% | -$43.3K | 0.45% | 60 |
|
|
2025
Q4 | $1.04M | Buy |
4,572
+162
| +4% | +$36.9K | 0.48% | 58 |
|
|
2025
Q3 | $1.02M | Sell |
4,410
-65
| -1% | -$13.2K | 0.49% | 59 |
|
|
2025
Q2 | $831K | Sell |
4,475
-45
| -1% | -$8.36K | 0.43% | 65 |
|
|
2025
Q1 | $947K | Sell |
4,520
-81
| -2% | -$15.7K | 0.54% | 63 |
|
|
2024
Q4 | $818K | Sell |
4,601
-29
| -0.6% | -$5.33K | 0.45% | 69 |
|
|
2024
Q3 | $914K | Sell |
4,630
-50
| -1% | -$9.33K | 0.5% | 70 |
|
|
2024
Q2 | $803K | Buy |
4,680
+1,450
| +45% | +$240K | 0.46% | 71 |
|
|
2024
Q1 | $588K | Sell |
3,230
-435
| -12% | -$75K | 0.25% | 101 |
|
|
2023
Q4 | $568K | Sell |
3,665
-75
| -2% | -$10.9K | 0.25% | 102 |
|
|
2023
Q3 | $557K | Sell |
3,740
-295
| -7% | -$43.3K | 0.27% | 99 |
|
|
2023
Q2 | $544K | Sell |
4,035
-832
| -17% | -$122K | 0.3% | 89 |
|
|
2023
Q1 | $776K | Sell |
4,867
-312
| -6% | -$47.7K | 0.39% | 82 |
|
|
2022
Q4 | $837K | Sell |
5,179
-23
| -0.4% | -$3.53K | 0.43% | 78 |
|
|
2022
Q3 | $698K | Sell |
5,202
-75
| -1% | -$10.8K | 0.38% | 83 |
|
|
2022
Q2 | $808K | Sell |
5,277
-65
| -1% | -$9.93K | 0.42% | 75 |
|
|
2022
Q1 | $866K | Sell |
5,342
-297
| -5% | -$43.1K | 0.39% | 76 |
|
|
2021
Q4 | $764K | Sell |
5,639
-416
| -7% | -$49.1K | 0.34% | 80 |
|
|
2021
Q3 | $653K | Sell |
6,055
-64
| -1% | -$7.31K | 0.31% | 85 |
|
|
2021
Q2 | $689K | Sell |
6,119
-171
| -3% | -$19.3K | 0.34% | 78 |
|
|
2021
Q1 | $681K | Sell |
6,290
-469
| -7% | -$50.2K | 0.36% | 76 |
|
|
2020
Q4 | $724K | Buy |
6,759
+452
| +7% | +$43.4K | 0.42% | 72 |
|
|
2020
Q3 | $552K | Sell |
6,307
-20
| -0.3% | -$1.88K | 0.37% | 74 |
|
|
2020
Q2 | $621K | Buy |
6,327
+448
| +8% | +$39.4K | 0.46% | 67 |
|
|
2020
Q1 | $448K | Sell |
5,879
-75
| -1% | -$6.39K | 0.39% | 71 |
|
|
2019
Q4 | $527K | Hold |
5,954
| – | – | 0.38% | 75 |
|
|
2019
Q3 | $451K | Hold |
5,954
| – | – | 0.37% | 73 |
|
|
2019
Q2 | $433K | Sell |
5,954
-90
| -1% | -$7.07K | 0.37% | 69 |
|
|
2019
Q1 | $487K | Buy |
6,044
+220
| +4% | +$18K | 0.43% | 63 |
|
|
2018
Q4 | $537K | Sell |
5,824
-366
| -6% | -$32.2K | 0.53% | 54 |
|
|
2018
Q3 | $585K | Sell |
6,190
-50
| -0.8% | -$4.74K | 0.51% | 55 |
|
|
2018
Q2 | $578K | Hold |
6,240
| – | – | 0.53% | 55 |
|
|
2018
Q1 | $590K | Buy |
6,240
+1,045
| +20% | +$115K | 0.56% | 51 |
|
|
2017
Q4 | $502K | Buy |
5,195
+50
| +1% | +$4.71K | 0.47% | 57 |
|
|
2017
Q3 | $457K | Sell |
5,145
-133
| -3% | -$10.1K | 0.44% | 56 |
|
|
2017
Q2 | $383K | Hold |
5,278
| – | – | 0.37% | 65 |
|
|
2017
Q1 | $344K | Sell |
5,278
-125
| -2% | -$7.86K | 0.35% | 71 |
|
|
2016
Q4 | $338K | Buy |
+5,403
| New | +$330K | 0.31% | 77 |
|
Other funds holding ABBV
ECSS
ATO
Norway Savings Bank's ABBV Position: Q2 2026 in Review
Norway Savings Bank reduced its AbbVie (ABBV) stake by 9.2% in Q2 2026, selling an estimated $86.5K and leaving 3,975 shares worth $1M. The position accounts for 0.42% of the portfolio, ranked #57.
Norway Savings Bank first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.04M in Q4 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Norway Savings Bank held 3,975 shares of AbbVie worth $1M as of Q2 2026.
- Norway Savings Bank sold 402 AbbVie shares in Q2 2026, an estimated $86.5K.
- AbbVie made up 0.42% of Norway Savings Bank's portfolio in Q2 2026, its #57 holding.
- Norway Savings Bank first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
- Norway Savings Bank's AbbVie position peaked at $1.04M in Q4 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.